Checkpoint Inhibitor and Radiotherapy for Recurrent Gastric Cancer (CIRCUIT)

NCT03453164 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

RADIATION: Radiotherapy
DRUG: Nivolumab

Sponsor

Fukushima Medical University